NASDAQ:ACRS   Aclaris Therapeutics, Inc
NASDAQ:ACRS
Possible Scenario: LONG
Evidence: Price Action
TP1: ~7
TP2: ~7.60
This is my idea and could be wrong 100%
no pain, no gain